uFraction8 Secures £3.4M to Optimise Cell and Biomass Production

Scottish biotech engineering company uFraction8 has secured £3.4 million in funding led by Foresight Group, with additional support from various investors including the University of Edinburgh and Scottish Enterprise. The company has developed microfiltration technology aimed at optimizing cell and biomass production, offering a sustainable and energy-efficient alternative to traditional methods used in the production of food, feed, and bio-based products. The funding will be used to commercialize the technology further and drive innovation in transforming microalgae industry production processes.

Co-founded by Dr. Brian Miller and Dr. Monika Tomecka, uFraction8 aims to build efficient and scalable perfusion solutions to improve processing microbial cell cultures, especially in areas like microalgae, cultivated meat, and biopharmaceutical applications. With previous funding rounds already completed, this new investment will help the company bring its solutions to market more rapidly, particularly within the microalgae and biopharma sectors, while also continuing its innovation within the alternative protein sector.